Emily Walkom
Impact in
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 5
-
- Pharmaceutical industry and healthcare 8
- Co-authors
- Jane RobertsonSuzanne HillAnthony HarrisJing Jing LiDavid NewbyPatricia McGettiganDavid HenryShu Chuen Li
- Journals
- International Journal of Pharmacy Practice (4 papers)PLoS ONE (2 papers)BMJ Open (1 paper)PLoS Medicine (1 paper)International Journal of Intercultural Relations (1 paper)
- Partner nations
- AustraliaCanadaUnited States
In The Last Decade
Emily Walkom
19 papers receiving 549 citations
Peers
Comparison fields: 5 of 109
- Geriatrics and Gerontology 75
- Medical Terminology 3
- Economics and Econometrics 258
- Family Practice 20
- Pharmacology 75
Countries citing papers authored by Emily Walkom
This map shows the geographic impact of Emily Walkom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Walkom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Walkom more than expected).
Fields of papers citing papers by Emily Walkom
This network shows the impact of papers produced by Emily Walkom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Walkom. The network helps show where Emily Walkom may publish in the future.
Co-authors
The 24 scholars most cited alongside Emily Walkom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 20 | |
| 2 | 2020 | 18 | |
| 3 | 2019 | 9 | |
| 4 | 2017 | 25 | |
| 5 | 2016 | 4 | |
| 6 | 2016 | 12 | |
| 7 | 2015 | 54 | |
| 8 | 2013 | 16 | |
| 9 | 2013 | 12 | |
| 10 | 2011 | 15 | |
| 11 | 2010 | 55 | |
| 12 | 2010 | 4 | |
| 13 | 2009 | 24 | |
| 14 | 2009 | 26 | |
| 15 | 2008 | 177 | |
| 16 | The role of pharmacoeconomics in formulary decision-making: considerations for hospital and managed care pharmacy and therapeutics committees | 2006 | 10 |
| 17 | 2005 | 60 | |
| 18 | 2001 | 35 | |
| 19 | 2000 | 2 |
About Emily Walkom
Emily Walkom is a scholar working on Geriatrics and Gerontology, Pharmacology, Economics and Econometrics, Family Practice and Health Information Management, having authored 19 papers that have together received 578 indexed citations. Recurring topics across this work include Pharmaceutical industry and healthcare (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (6 papers), Pharmaceutical Practices and Patient Outcomes (5 papers), Healthcare Policy and Management (3 papers), Healthcare cost, quality, practices (2 papers), Global Health Care Issues (2 papers) and Mental Health Treatment and Access (2 papers). The work is most often cited by research in Geriatrics and Gerontology (75 citations), Medical Terminology (3 citations), Economics and Econometrics (258 citations), Family Practice (20 citations) and Pharmacology (75 citations). Emily Walkom has collaborated with scholars based in Australia, Canada and United States. Frequent co-authors include Jane Robertson, Suzanne Hill, Anthony Harris, Jing Jing Li, David Newby, Patricia McGettigan, David Henry, Shu Chuen Li, Ray Moynihan and Lisa Bero. Their work appears in journals such as International Journal of Pharmacy Practice, PLoS ONE, BMJ Open, PLoS Medicine and International Journal of Intercultural Relations.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.